TactiCath Post Market Approval Study

Brief Description Of Study

The purpose of the research study is to obtain additional information safety and effectiveness of an FDA approved catheter when used to treat patients with Paroxysmal atrial fibrillation.

Clinical Study Identifier: TX1017

Detailed Study Description

The purpose of the study is to provide data and safety for the Food and Drug administration (FDA). The study is designed for patients with paroxysmal atrial fibrillation. Participants will only be enrolled if at the time of consent present with paroxysmal atrial fibrillation and meet criteria for an ablation procedure. The study is seeking participants willing to be followed for a period of 5 years

Contact research investigator to learn more about this study by filling out the form below.

To: Research Study Investigator
Subject: I am interested in participating in your Research Study
Dear Investigator,
I'm interested in learning more about and participating in your research study named: TactiCath Post Market Approval Study
I am hoping to hear back from you and discuss details of the study

By clicking "Contact Research Team", your contact information will be sent directly to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.